Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | 442.9% | 6,601.1% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 55.1% | 52.6% | 100% |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -67.7% | -288.7% | -35,418.4% |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -84.1% | -367.6% | -36,173.7% |
| EPS Diluted | -8.6 | -8.31 | -12.96 |
| % Growth | -3.5% | 35.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 |